Literature DB >> 12189386

Epithelial-mesenchymal transitions in tumour progression.

Jean Paul Thiery1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189386     DOI: 10.1038/nrc822

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2000 in total

1.  Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells.

Authors:  Chun-Te Wu; Ching-Chuan Hsieh; Cheng-Chia Lin; Wen-Cheng Chen; Ji-Hong Hong; Miao-Fen Chen
Journal:  J Mol Med (Berl)       Date:  2012-06-03       Impact factor: 4.599

Review 2.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

3.  Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.

Authors:  Runlin Shi; Haibing Xiao; Tao Yang; Lei Chang; Yuanfeng Tian; Bolin Wu; Hua Xu
Journal:  Front Med       Date:  2014-11-03       Impact factor: 4.592

Review 4.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

Review 5.  VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.

Authors:  Xiaochong Deng; Lin Fang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

6.  A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.

Authors:  Yi-Fan Zhao; Mei-Ling Han; Ya-Jie Xiong; Long Wang; Yao Fei; Xiao Shen; Ying Zhu; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

7.  HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.

Authors:  Sugiko Watanabe; Yasuaki Ueda; Shin-ichi Akaboshi; Yuko Hino; Yoko Sekita; Mitsuyoshi Nakao
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.

Authors:  M G di Bari; E Ginsburg; J Plant; L Strizzi; D S Salomon; B K Vonderhaar
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

9.  ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells.

Authors:  Jonathan Clarhaut; Robert M Gemmill; Vincent A Potiron; Slimane Ait-Si-Ali; Jean Imbert; Harry A Drabkin; Joëlle Roche
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

10.  Insights into the epithelial mesenchymal transition phenotype in cancer of unknown primary from a global microRNA profiling study.

Authors:  A Stoyianni; G Pentheroudakis; H Benjamin; A Cervantes; K Ashkenazi; G Lazaridis; N Pavlidis; Y Spector
Journal:  Clin Transl Oncol       Date:  2013-11-27       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.